Abstract
Head and neck cancer is the seventh most common cancer in Brazil and affects 15,000 patients yearly. Despite the advancements brought to the field in the past several years the treatment remains a challenge regarding its specificity. Importantly, nowadays we are still lacking biomarkers in order to foresee the prognosis of this devastating disease. Consequently, aggressive surgeries for t…